Targets for Heart Failure With Preserved Ejection Fraction.

about

Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.Affairs of the Heart: Innovation in Cardiovascular Research and Development.

P2860

Q50099011-85A661EF-F44C-4F65-8F19-DB1854C93C34 Q53157206-29A8A0BA-ECDB-4CE4-84D7-E415C8304FB4

P2860

Targets for Heart Failure With Preserved Ejection Fraction.

Item

http://www.wikidata.org/entity/Q38688194

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Targets for Heart Failure With Preserved Ejection Fraction.

@en

type

Item

label

Targets for Heart Failure With Preserved Ejection Fraction.

@en

prefLabel

Targets for Heart Failure With Preserved Ejection Fraction.

@en

P1476

Targets for Heart Failure With Preserved Ejection Fraction

@en

P2093

D M Kaye

http://www.w3.org/2001/XMLSchema#string

P2860

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation

Angiotensin II, NADPH oxidase, and redox signaling in the vasculature

Calcium mishandling in diastolic dysfunction: mechanisms and potential therapies

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Nitric oxide synthases: regulation and function

Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.

Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction.

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study

P304

228-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPT.723

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Shane Nanayakkara

P577

2017-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28466986

http://www.w3.org/2001/XMLSchema#string

Targets for Heart Failure With Preserved Ejection Fraction.

about

P2860

P2860

Targets for Heart Failure With Preserved Ejection Fraction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698